11672554falseDispensing chemist in specialised stores2024-04-012025-03-31http://www.companieshouse.gov.uk/2024-03-31http://www.companieshouse.gov.uk/pt:ShareCapital2024-03-31http://www.companieshouse.gov.uk/cd:Director12024-04-012025-03-31http://www.companieshouse.gov.uk/pt:SharePremium2024-03-31http://www.companieshouse.gov.uk/pt:ShareCapital2025-03-31http://www.companieshouse.gov.uk/cd:Director22024-04-012025-03-31http://www.companieshouse.gov.uk/pt:SharePremium2025-03-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12024-04-012025-03-31http://www.companieshouse.gov.uk/cd:RegisteredOffice2024-04-012025-03-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2024-04-012025-03-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2025-03-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2024-03-31http://www.companieshouse.gov.uk/2024-04-012025-03-31http://www.companieshouse.gov.uk/2024-03-31http://www.companieshouse.gov.uk/cd:FRS1022024-04-012025-03-31http://www.companieshouse.gov.uk/2025-03-31http://www.companieshouse.gov.uk/cd:FullAccounts2024-04-012025-03-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2024-04-012025-03-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 11672554

H S PHARMA (BRISTOL) LTD

UNAUDITED ACCOUNTS
FOR THE YEAR ENDED 31/03/2025


H S PHARMA (BRISTOL) LTD

ACCOUNTS
FOR THE YEAR ENDED 31/03/2025
DIRECTORS
A M Sadiq
H Sadiq
REGISTERED OFFICE
58 Flax Bourton Road,
Failand
Bristol
BS8 3UN
COMPANY DETAILS
Private company limited by shares registered in EW - England and Wales, registered number 11672554

H S PHARMA (BRISTOL) LTD

ACCOUNTS
FOR THEYEARENDED31/03/2025
CONTENTS
Page
Balance Sheet3-4
Notes To The Accounts5-7

H S PHARMA (BRISTOL) LTD

BALANCE SHEET AT 31/03/2025
20252024
Notes££
FIXED ASSETS
Tangible assets3254,132251,072
CURRENT ASSETS
Stock85,00067,000
Debtors580,303102,586
Cash at bank and in hand75,93183,399
241,234252,985
CREDITORS: Amounts falling due within one year6155,086153,272
NET CURRENT ASSETS86,14899,713
TOTAL ASSETS LESS CURRENT LIABILITIES340,280350,785
CREDITORS: Amounts falling due after more than one year73,6823,814
NET ASSETS336,598346,971
CAPITAL AND RESERVES
Called up share capital822
Share premium account9336,084336,084
Profit and loss account51210,885
SHAREHOLDERS' FUNDS336,598346,971

H S PHARMA (BRISTOL) LTD

BALANCE SHEET AT 31/03/2025
For the year ending 31/03/2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account.
Approved by the board on 15/12/2025 and signed on their behalf by
A M Sadiq
Director
H Sadiq
Director

H S PHARMA (BRISTOL) LTD

NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31/03/2025
1. ACCOUNTING POLICIES
1a. Basis Of Accounting
The accounts have been prepared under the historical cost convention.
The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 .
1b. Depreciation
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.
Plant and Machineryreducing balance 25%
Fixtures and Fittingsreducing balance 15%
Equipmentreducing balance 25%
1c. Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.
When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs.
1d. Pension Costs
The company operates a defined contribution pension scheme. The pension charge represents the amounts payable by the company to the fund in respect of the year.
2. EMPLOYEES
20252024
No.No.
Average number of employees119

H S PHARMA (BRISTOL) LTD

3. TANGIBLE FIXED ASSETS
Land AndPlant and
BuildingsMachinery Etc.Total
£££
Cost
At 01/04/2024234,95743,140278,097
Additions-7,3887,388
At 31/03/2025234,95750,528285,485
Depreciation
At 01/04/2024-27,02527,025
For the year-4,3284,328
At 31/03/2025-31,35331,353
Net Book Amounts
At 31/03/2025234,95719,175254,132
At 31/03/2024234,95716,115251,072
4. STOCK 20252024
££
Stock comprises:
Stock85,00067,000
85,00067,000
5. DEBTORS 20252024
££
Amounts falling due within one year:
Trade debtors37,87767,810
VAT18,57417,645
Other debtors23,85217,131
80,303102,586

H S PHARMA (BRISTOL) LTD

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
20252024
££
Bank loans and overdrafts2,5982,598
Trade creditors131,162130,690
Taxation and social security13,36917,508
Other creditors7,9572,476
155,086153,272
7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
20252024
££
Bank loans and overdrafts3,6823,814
3,6823,814
Included in other creditors are:
8. SHARE CAPITAL 20252024
££
Allotted, issued and fully paid:
2 Ordinary shares of £1 each22
22
9. SHARE PREMIUM ACCOUNT 20252024
££
Share premium account336,084336,084